Steven Seedhouse

Stock Analyst at Cantor Fitzgerald

(3.59)
# 856
Out of 5,042 analysts
179
Total ratings
46.82%
Success rate
6.86%
Average return

Stocks Rated by Steven Seedhouse

BioCryst Pharmaceuticals
Oct 15, 2025
Maintains: Overweight
Price Target: $24$26
Current: $7.20
Upside: +261.11%
89bio
Sep 19, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $14.79
Upside: -
Astria Therapeutics
Sep 17, 2025
Reiterates: Overweight
Price Target: $49
Current: $12.44
Upside: +293.89%
Dianthus Therapeutics
Sep 9, 2025
Reiterates: Outperform
Price Target: $56$63
Current: $32.92
Upside: +91.37%
Korro Bio
Aug 13, 2025
Maintains: Strong Buy
Price Target: $153$147
Current: $38.09
Upside: +285.93%
Mirum Pharmaceuticals
Aug 7, 2025
Maintains: Strong Buy
Price Target: $77$82
Current: $70.02
Upside: +17.11%
Wave Life Sciences
Apr 29, 2025
Initiates: Overweight
Price Target: $10
Current: $7.13
Upside: +40.25%
Pharvaris
Apr 29, 2025
Initiates: Overweight
Price Target: $28
Current: $22.99
Upside: +21.79%
InflaRx
Apr 29, 2025
Initiates: Overweight
Price Target: $10
Current: $1.40
Upside: +614.29%
Viking Therapeutics
Apr 28, 2025
Initiates: Overweight
Price Target: $104
Current: $34.42
Upside: +202.15%
Downgrades: Outperform
Price Target: $90$22
Current: $2.97
Upside: +640.74%
Upgrades: Strong Buy
Price Target: $6$14
Current: $2.94
Upside: +376.19%
Upgrades: Outperform
Price Target: $93
Current: $120.94
Upside: -23.10%
Maintains: Strong Buy
Price Target: $57$68
Current: $29.22
Upside: +132.72%
Maintains: Strong Buy
Price Target: $67$106
Current: $28.17
Upside: +276.29%
Maintains: Strong Buy
Price Target: $12$15
Current: $5.04
Upside: +197.62%
Maintains: Strong Buy
Price Target: $27$56
Current: $17.12
Upside: +227.10%
Maintains: Outperform
Price Target: $19$18
Current: $0.48
Upside: +3,557.26%
Maintains: Outperform
Price Target: $78$57
Current: $25.60
Upside: +122.66%
Maintains: Strong Buy
Price Target: $20$22
Current: $3.69
Upside: +496.21%
Upgrades: Outperform
Price Target: $17
Current: $3.72
Upside: +356.99%
Maintains: Outperform
Price Target: $33$35
Current: $3.85
Upside: +809.09%
Upgrades: Outperform
Price Target: $38
Current: $58.56
Upside: -35.11%
Maintains: Strong Buy
Price Target: $30$71
Current: $49.15
Upside: +44.46%
Maintains: Outperform
Price Target: $15$5
Current: $2.48
Upside: +101.61%
Maintains: Outperform
Price Target: $30$38
Current: $35.07
Upside: +8.35%
Downgrades: Underperform
Price Target: n/a
Current: $11.22
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $1.38
Upside: -
Maintains: Outperform
Price Target: $285$270
Current: $12.69
Upside: +2,027.66%
Downgrades: Sell
Price Target: n/a
Current: $149.89
Upside: -